scispace - formally typeset
A

Aline Borsato Hauser

Researcher at Federal University of Paraná

Publications -  19
Citations -  337

Aline Borsato Hauser is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Kidney disease & Medicine. The author has an hindex of 7, co-authored 16 publications receiving 305 citations. Previous affiliations of Aline Borsato Hauser include Pontifícia Universidade Católica do Paraná.

Papers
More filters
Journal ArticleDOI

Characteristics and causes of immune dysfunction related to uremia and dialysis

TL;DR: Understanding the mechanisms behind the immune dysfunction that is peculiar to CKD generates a perspective to improve outcomes in this group of patients and targets for interventions aiming to reduce mortality in CKD patients.
Journal ArticleDOI

A gut feeling on endotoxemia: causes and consequences in chronic kidney disease.

TL;DR: It is proposed that there are several potential sources of endotoxemia in CKD and that gut translocation, leading to the generation of ligands of the innate immune response, represents a potentially reversible cause.
Journal ArticleDOI

Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia.

TL;DR: It is concluded that sevelamer treatment leads to a decrease in hsCRP levels, which was accompanied by a parallel decrease in endotoxemia, suggesting that endotoxemsia may contribute to the systemic inflammation in HD patients,Which was partially reduced by the use of seVELamer.
Journal ArticleDOI

Sevelamer Carbonate Reduces Inflammation and Endotoxemia in an Animal Model of Uremia

TL;DR: Induction of renal failure triggered inflammation and induced endotoxemia in this experimental model of chronic kidney disease, which were reduced by sevelamer treatment, which suggests that seVELamer carbonate induces an anti-inflammatory effect in parallel to a reduction in ET.
Journal ArticleDOI

Association between Albuminuria, Glomerular Filtration Rate and Mortality or Recurrence in Stroke Patients

TL;DR: The presence of AUr >17 mg/g is independently associated with death or recurrence after stroke, and further studies should consider the AUr as a predictor for a worse prognosis in these patients.